Cargando…
Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus
BACKGROUND: Clinically meaningful endpoints for respiratory syncytial virus (RSV) treatment trials are lacking for hematopoietic cell transplant (HCT) recipients. We evaluated supplemental oxygen use among HCT recipients with RSV infection. METHODS: Subjects were grouped according to the presence of...
Autores principales: | Waghmare, Alpana, Xie, Hu, Kimball, Louise, Yi, Jessica, Özkök, Sezen, Leisenring, Wendy, Cheng, Guang-Shing, Englund, Janet A, Watkins, Timothy R, Chien, Jason W, Boeckh, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853655/ https://www.ncbi.nlm.nih.gov/pubmed/28961971 http://dx.doi.org/10.1093/infdis/jix390 |
Ejemplares similares
-
923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Xie, Hu, et al.
Publicado: (2021) -
Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
por: Ogimi, Chikara, et al.
Publicado: (2017) -
Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution
por: Ogimi, Chikara, et al.
Publicado: (2017) -
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
por: Kim, Yae-Jean, et al.
Publicado: (2014) -
Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes
por: Waghmare, Alpana, et al.
Publicado: (2013)